Literature DB >> 22130586

Complete the Following Statement: Industry-Sponsored Antiepileptic Drug Pregnancy Registries Provide Information that is Beneficial to:: PatientsDoctorsThe SponsorAll of the AboveNone of the AboveCannot Respond Due to Risk of COI.

Cynthia L Harden.   

Abstract

Entities:  

Year:  2011        PMID： 22130586      PMCID： PMC3220421          DOI： 10.5698/1535-7511-11.6.181

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  11 in total

1.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.

Authors:  J Morrow; A Russell; E Guthrie; L Parsons; I Robertson; R Waddell; B Irwin; R C McGivern; P J Morrison; J Craig
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09-12       Impact factor: 10.154

2.  The Pregnancy Registry program at Glaxo Wellcome Company.

Authors:  A D White; E B Andrews
Journal:  J Allergy Clin Immunol       Date:  1999-02       Impact factor: 10.793

3.  Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment.

Authors:  R Reiff-Eldridge; C R Heffner; S A Ephross; P S Tennis; A D White; E B Andrews
Journal:  Am J Obstet Gynecol       Date:  2000-01       Impact factor: 8.661

4.  Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.

Authors:  Torbjörn Tomson; Dina Battino; Erminio Bonizzoni; John Craig; Dick Lindhout; Anne Sabers; Emilio Perucca; Frank Vajda
Journal:  Lancet Neurol       Date:  2011-06-05       Impact factor: 44.182

5.  Final results from 18 years of the International Lamotrigine Pregnancy Registry.

Authors:  M C Cunnington; J G Weil; J A Messenheimer; S Ferber; M Yerby; P Tennis
Journal:  Neurology       Date:  2011-05-24       Impact factor: 9.910

6.  Lamotrigine and the risk of malformations in pregnancy.

Authors:  Marianne Cunnington; Patricia Tennis
Journal:  Neurology       Date:  2005-03-22       Impact factor: 9.910

7.  Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study.

Authors:  Marianne Cunnington; Sandy Ferber; George Quartey
Journal:  Epilepsia       Date:  2007-03-22       Impact factor: 5.864

8.  Newer-generation antiepileptic drugs and the risk of major birth defects.

Authors:  Ditte Mølgaard-Nielsen; Anders Hviid
Journal:  JAMA       Date:  2011-05-18       Impact factor: 56.272

9.  Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy.

Authors:  L B Holmes; E J Baldwin; C R Smith; E Habecker; L Glassman; S L Wong; D F Wyszynski
Journal:  Neurology       Date:  2008-04-30       Impact factor: 9.910

10.  Preliminary results on pregnancy outcomes in women using lamotrigine.

Authors:  Patricia Tennis; R R Eldridge
Journal:  Epilepsia       Date:  2002-10       Impact factor: 5.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.